重组人Nogo-66受体(NgR)(RTN-4R)(内质网蛋白4受体)

特别提示：包括重组人Nogo-66受体(NgR)(RTN-4R)(内质网蛋白4受体)在内，本公司的所有产品仅可用于科研实验，严禁用于临床YL及其他非科研用途！

产品名称：重组人Nogo-66受体(NgR)(RTN-4R)(内质网蛋白4受体)
英文名称：Recombinant Human Nogo-66 Receptor/Reticulon 4 Receptor
产品货号：JN0650
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Cys27-Ser447在C端含有His标签。

Nogo Receptor/NgR质量控制：＞95%(还原性SDS-PAGE)

Nogo Receptor/NgR制剂：冻干品

Nogo Receptor/NgR保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

Nogo Receptor/NgR复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于Nogo Receptor/NgR：
Nogo Receptor (NgR) is a glycosylphosphoinositol (GPI)-anchored protein that belongs to the Nogo recptor family. Human NgR is predominantly expressed in neurons and their axons in the central nervous systems. As a receptor for myelin-derived proteins Nogo, myelin-associated glycoprotein (MAG) and myelin oligodendrocyte glycoprotein (OMG), NgR mediates axonal growth inhibition and may play a role in regulating axonal regeneration and plasticity in the adult central nervous system. NgR may be proposed as a potential drug target for treatment of various neurological conditions. Additionally, NgR may play a role in regulating the function of gap junctions.

我公司销售的重组人Nogo-66受体(NgR)(RTN-4R)(内质网蛋白4受体)，重组NgR，重组Nogo-66 Receptor/Reticulon 4 Receptor，Recombinant Human Nogo-66 Receptor/Reticulon 4 Receptor，重组人Nogo-66受体，rhRTN-4R，重组人RTN-4R，重组Nogo-66受体，rRTN-4R，重组内质网蛋白4受体，rhNgR，重组人NgR，重组RTN-4R，重组人内质网蛋白4受体，重组人Nogo-66 Receptor/Reticulon 4 Receptor，rNgR质量上佳，价格普惠，欢迎广大新老客户踊跃订购。